［1］ZHANG BH，YUE HY.Cell entanglement：A new hypothesis of the origin of cancer［J］.Modern Oncology，2015，23（20）：3048-3049.［张百红，岳红云.细胞纠缠：肿瘤起源的新假说［J］.现代肿瘤医学，2015，23（20）：3048-3049.］
［2］YUE HY，ZHANG BH.Evidences of cell entanglement［J］.Modern Oncology，2016，24（14）：2331-2332.［岳红云，张百红.细胞纠缠存在的几点证据［J］.现代肿瘤医学，2016，24（14）：2331-2332.］
［3］ZHANG BH，YUE HY.Proving cell entanglement at single live cells［J］.Modern Oncology，2016，24（22）：3652-3653.［张百红，岳红云.证明细胞纠缠［J］.现代肿瘤医学，2016，24（22）：3652-3653.］
［4］Palii A，Tsukerblat B.Tuning of quantum entanglement in molecular quantum cellular automata based on mixed-valence tetrameric units［J］.Dalton Trans，2016，45(42)：16661-16672.
［5］Puisieux A，Pommier RM，Morel AP，et al.Cellular pliancy and the multistep process of tumorigenesis［J］.Cancer Cell，2018，33(2)：164-172.
［6］Pilié PG，Tang C，Mills GB，et al.State-of-the-art strategies for targeting the DNA damage response in cancer［J］.Nat Rev Clin Oncol，2019，16(2)：81-104.
［7］Iranzo J，Martincorena I，Koonin EV.Cancer-mutation network and the number and specificity of driver mutations［J］.Proc Natl Acad Sci USA，2018，115(26)：E6010-E6019.
［8］Pich O，Muinos F，Sabarinathan R，et al.Somatic and germline mutation periodicity follow the orientation of the dna minor groove around nucleosomes［J］.Cell，2018，175(4)：1074-1087.e18.
［9］Greaves M.When one mutation is all it takes［J］.Cancer Cell，2015，27(4)：433-434.
［10］Sottoriva A，Kang H，Ma Z，et al.A Big Bang model of human colorectal tumor growth［J］.Nat Genet，2015，47(3)：209-216.
［11］Notta F，Chan-Seng-Yue M，Lemire M，et al.A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns［J］.Nature，2016，538(7625)：378-382.
［12］Alexandrov LB，Jones PH，Wedge DC，et al.Clock-like mutational processes in human somatic cells［J］.Nat Genet，2015，47(12)：1402-1407.
［13］Zhang D，Zhao S，Li X，et al.Prostate luminal progenitor cells in development and cancer［J］.Trends Cancer，2018，4(11)：769-783.
［14］Fridriksdottir AJ，Villadsen R，Morsing M，et al.Proof of region-specific multipotent progenitors in human breast epithelia［J］.Proc Natl Acad Sci USA，2017，114(47)：E10102-E10111.
［15］Ghaderi A，Abtahi S.Mesenchymal stem cells：Miraculous healers or dormant killers［J］?Stem Cell Rev，2018，14(5)：722-733.
［16］Ge Y，Fuchs E.Stretching the limits：from homeostasis to stem cell plasticity in wound healing and cancer［J］.Nat Rev Genet，2018，19(5)：311-325.
［17］Katajisto P，Dohla J，Chaffer CL，et al. Stem cells.Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness［J］.Science，2015，348(6232)：340-343.
［18］Tomasetti C，Vogelstein B.Cancer etiology.Variation in cancer risk among tissues can be explained by the number of stem cell divisions［J］.Science，2015，347(6217)：78-81.
［19］Dongre A，Weinberg RA.New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer［J］.Nat Rev Mol Cell Biol，2019，20(2)：69-84.
［20］Liu T，Xu H，Huang M，et al.Circulating glioma cells exhibit stem cell-like properties［J］.Cancer Res，2018，78(23)：6632-6642.
［21］Pascual G，Avgustinova A，Mejetta S，et al.Targeting metastasis-initiating cells through the fatty acid receptor CD36［J］.Nature，2017，541(7635)：41-45.
［22］Lawson DA，Bhakta NR，Kessenbrock K，et al.Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells［J］.Nature，2015，526(7571)：131-135.
［23］Mong J，Tan MH.Size-based enrichment technologies for non-cancerous tumor-derived cells in blood［J］.Trends Biotechnol，2018，36(5)：511-522.
［24］Najafi M，Farhood B，Mortezaee K.Cancer stem cells (CSCs) in cancer progression and therapy［J］.J Cell Physiol，2019，234(6)：8381-8395.
［25］Chen X，Song E.Turning foes to friends：targeting cancer-associated fibroblasts［J］.Nat Rev Drug Discov，2019，18(2)：99-115.
［26］Han Y，Liu Q，Hou J，et al.Tumor-Induced generation of splenic erythroblast-like ter-cells promotes tumor progression［J］.Cell，2018，173(3)：634-648.e12.
［27］Roerink SF，Sasaki N，Lee-Six H，et al.Intra-tumour diversification in colorectal cancer at the single-cell level［J］.Nature，2018，556(7702)：457-462.
［28］Reeves MQ，Kandyba E，Harris S，et al.Multicolour lineage tracing reveals clonal dynamics of squamous carcinoma evolution from initiation to metastasis［J］.Nat Cell Biol，2018，20(6)：699-709.
［29］Ryser MD，Min BH，Siegmund KD，et al.Spatial mutation patterns as markers of early colorectal tumor cell mobility［J］.Proc Natl Acad Sci USA，2018，115(22)：5774-5779.
［30］McGranahan N，Swanton C.Clonal heterogeneity and tumor evolution：Past，present，and the future［J］.Cell，2017，168(4)：613-628.
［31］Turner NC，Slamon DJ，Ro J，et al.Overall survival with palbociclib and fulvestrant in advanced breast cancer［J］.N Engl J Med，2018，379(20)：1926-1936.
［32］Lytle NK，Barber AG，Reya T.Stem cell fate in cancer growth，progression and therapy resistance［J］.Nat Rev Cancer，2018，18(11)：669-680.
［33］Sánchez-Danés A，Blanpain C.Deciphering the cells of origin of squamous cell carcinomas［J］.Nat Rev Cancer，2018，18(9)：549-561.
［34］Mayers JR，Torrence ME，Danai LV，et al.Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers［J］.Science，2016，353(6304)：1161-1165.
［35］Bu W，Liu Z，Jiang W，et al.Mammary precancerous stem and non-stem cells evolve into cancers of distinct subtypes［J］.Cancer Res，2019，79(1)：61-71.
［36］Lin VTG，Pruitt HC，Samant RS，et al.Developing cures：Targeting ontogenesis in cancer［J］.Trends Cancer，2017，3(2)：126-136.
［37］McFarlane RJ，Wakeman JA.Meiosis-like functions in oncogenesis：A new view of cancer［J］.Cancer Res，2017，77(21)：5712-5716.
［38］Laplane L，Duluc D，Larmonier N，et al.The multiple layers of the tumor environment［J］.Trends Cancer，2018，4(12)：802-809.
［39］Liu H，Kiseleva AA，Golemis EA.Ciliary signalling in cancer［J］.Nat Rev Cancer，2018，18(8)：511-524.